Position in NVCT
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$97,954
+$2,282 QoQ
Shares Held
12,672
0.0% QoQ
Ownership
0.048%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
5 quarters on record
Voting authority
Sole 3%
Shared 0%
None 97%
Common Shares in NVCT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DEUTSCHE BANK AG\ holds $2,976,719,496 across 248 Biotechnology names. NVCT ranks #229 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,537,736 | $686,660,626 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
625,388 | $483,199,777 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
761,464 | $251,945,590 | |
| 4 | INCY |
Incyte Corp
|
1,264,195 | $118,986,027 | |
| 5 | RPRX |
Royalty Pharma plc
|
2,453,303 | $117,684,942 | |
| 6 | ARGX |
Argenx SE
|
139,381 | $101,782,972 | |
| 7 | INSM |
INSMED Inc
|
562,474 | $91,975,745 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
306,111 | $61,115,059 |
All Filings in NVCT
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $97,954 | 12,672 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $95,672 | 12,672 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $2,022 | 336 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $96,735 | 12,950 | Shares | Defined | 2025-08-12 | |
| 2024-03-31 | $28,773 | 3,509 | Shares | Defined | 2025-06-02 | |
| No filing history on record for this holder in this stock. | ||||||